BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20430875)

  • 1. Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype.
    Burdyga G; Varro A; Dimaline R; Thompson DG; Dockray GJ
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G63-9. PubMed ID: 20430875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.
    Burdyga G; Lal S; Varro A; Dimaline R; Thompson DG; Dockray GJ
    J Neurosci; 2004 Mar; 24(11):2708-15. PubMed ID: 15028763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance.
    Burdyga G; Varro A; Dimaline R; Thompson DG; Dockray GJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1289-97. PubMed ID: 16423919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin.
    de Lartigue G; Dimaline R; Varro A; Dockray GJ
    J Neurosci; 2007 Mar; 27(11):2876-82. PubMed ID: 17360909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fat diet and body weight have different effects on cannabinoid CB(1) receptor expression in rat nodose ganglia.
    Cluny NL; Baraboi ED; Mackie K; Burdyga G; Richard D; Dockray GJ; Sharkey KA
    Auton Neurosci; 2013 Dec; 179(1-2):122-30. PubMed ID: 24145047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High fat diet induced obesity alters endocannabinoid and ghrelin mediated regulation of components of the endocannabinoid system in nodose ganglia.
    Christie S; O'Rielly R; Li H; Wittert GA; Page AJ
    Peptides; 2020 Sep; 131():170371. PubMed ID: 32659299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach.
    Burdyga G; de Lartigue G; Raybould HE; Morris R; Dimaline R; Varro A; Thompson DG; Dockray GJ
    J Neurosci; 2008 Nov; 28(45):11583-92. PubMed ID: 18987194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans.
    Burdyga G; Lal S; Spiller D; Jiang W; Thompson D; Attwood S; Saeed S; Grundy D; Varro A; Dimaline R; Dockray GJ
    Gastroenterology; 2003 Jan; 124(1):129-39. PubMed ID: 12512037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats.
    de Lartigue G; Barbier de la Serre C; Espero E; Lee J; Raybould HE
    PLoS One; 2012; 7(3):e32967. PubMed ID: 22412960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
    Ting CH; Chi CW; Li CP; Chen CY
    Nutrition; 2015 Jan; 31(1):230-5. PubMed ID: 25466669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine- and amphetamine-regulated transcript mediates the actions of cholecystokinin on rat vagal afferent neurons.
    De Lartigue G; Dimaline R; Varro A; Raybould H; De la Serre CB; Dockray GJ
    Gastroenterology; 2010 Apr; 138(4):1479-90. PubMed ID: 19854189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
    Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.
    Hong S; Fan J; Kemmerer ES; Evans S; Li Y; Wiley JW
    Gut; 2009 Feb; 58(2):202-10. PubMed ID: 18936104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
    Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA
    Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The versatility of the vagus.
    Dockray GJ
    Physiol Behav; 2009 Jul; 97(5):531-6. PubMed ID: 19419683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats.
    Feng CC; Yan XJ; Chen X; Wang EM; Liu Q; Zhang LY; Chen J; Fang JY; Chen SL
    Pain; 2014 Aug; 155(8):1591-1604. PubMed ID: 24813296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of capsaicin-sensitive lung vagal afferents by anandamide in rats: role of transient receptor potential vanilloid 1 receptors.
    Lin YS; Lin RL; Bien MY; Ho CY; Kou YR
    J Appl Physiol (1985); 2009 Apr; 106(4):1142-52. PubMed ID: 19131477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition.
    Orio L; Crespo I; López-Moreno JA; Reyes-Cabello C; Rodríguez de Fonseca F; Gómez de Heras R
    Pharmacol Biochem Behav; 2011 Apr; 98(2):220-6. PubMed ID: 21163296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
    Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.